Search

MDs To Be / BY: Alessandro Cau, BSc (Hons) November 2022
Background Four million people currently live with chronic kidney disease in Canada, ... cotransporter-2 inhibitor (SGLT2i), in patients with type 2 diabetes, empagliflozin use was unexpectedly found to ... factors such as patient comorbidities and side effect profiles as well as which SGLT2i have documented renal and ...
Premise / BY: Murray Allen, MD October 2002
... enforcement agencies try to uncover the frauds. For most people, the threat of criminal prosecutions and penalties are ... claims of whiplash injury without much hesitation. This type of behavior by health professionals is also rational ... to identify different groups of people with different risk profiles and charge them according to the extent to which ...